PMID: 3322352Dec 1, 1987Paper

Treatment of angina pectoris with nifedipine: a double blind comparison of nifedipine and slow-release nifedipine alone and in combination with atenolol

British Heart Journal
T CrakeK M Fox

Abstract

The relative efficacy of nifedipine and slow-release nifedipine (Adalat Retard) in the treatment of stable exertional angina pectoris was evaluated in a double blind randomised crossover study in eight patients on no concomitant antianginal treatment and in 10 patients who were additionally on atenolol. Patients were assessed by angina diaries and exercise testing. Slow-release nifedipine was as effective as nifedipine in the treatment of these patients, both alone and in combination with atenolol.

Citations

Jan 1, 1991·European Journal of Clinical Pharmacology·B W KarlsonG Olsson
Aug 1, 1990·Cardiovascular Drugs and Therapy·D G Waller, V F Challenor
Aug 1, 1990·Cardiovascular Drugs and Therapy·R W Nesto
Mar 1, 1990·British Journal of Clinical Pharmacology·S Y MartsevichV A Vygodin
Nov 1, 1989·British Journal of Clinical Pharmacology·V F ChallenorC F George

❮ Previous
Next ❯

Related Concepts

Related Feeds

Antianginal Drugs: Mechanisms of Action

Antianginal drugs, including nitrates, beta-blockers, and calcium channel blockers, are used in the treatment of angina pectoris. Here is the latest research on their use and their mechanism of action.